-+ 0.00%
-+ 0.00%
-+ 0.00%

SYNDAX PHARMACEUTICALS - KEITH A. GOLDAN TO RETIRE AS CFO AND REMAIN THROUGH END OF 2026

Reuters·11/02/2026 21:01:01

Please log in to view news